Jewish Genetic Disease: New Advances in Detection and Treatment®
New Jersey Jewish News along with Barnabas Health, Pfizer and Jewish Family Service of MetroWest New Jersey for the latest installment of this series exploring issues that directly impact the local Jewish population.
1 in 4 Jews is a carrier for at least 1 of 19 preventable Jewish genetic diseases, and yet most people are unaware of simple detection options and available treatments. At this informative conference, you will get an overview of the diseases and screening methods and you will hear from a distinguished group of speakers who will share their expertise in more specific areas.
The speakers include:
- N. Peter Zauber, M.D, a private practitioner based in Livingston and also an attending in the department of Medicine at Cooperman Barnabas Medical Center, who will speak about his ongoing evaluation of Ashkenazi Jews who have had a colonoscopy for possible inherited genetic changes, as well as acquired genetic changes of colon tumors.
- Michael Wajnrajch MD, Senior Medical Director, Pfizer, Inc who will speak more specifically about the most common Jewish genetic disease and a treatment option developed in Israel.
- Martin Freifeld MD, Patient Ambassador, who will speak of his experience living with and managing this disease.
This is a vitally important issue to the local Jewish community and we hope that you will make it a priority to attend.
RSVP by Friday, October 31 to Beryll Kaplan, bkaplan@njjewishnews.com, (973) 929-3132
Doors open: 6:30 pm
Program: 7:00 pm – 8:30 pm
FREE OF CHARGE